More
    Guided Solutions - Connecting Talent With Innovation/div>

    Clinical Trials

    iRhythm has positive post-market study results for next-gen Zio

    iRhythm Technologies announced initial research findings on its Zio monitor’s post-market, real-world performance. The company presented the data on its next-generation long-term continuous monitoring...

    ExThera Medical’s OSCAR I Study enrols first pancreatic cancer treatment patient

    ExThera Medical’s OSCAR I Study (ONCObind CTC Removal Study), aimed at treating Metastatic Pancreatic Ductal Adenocarcinoma (PDAC), has enrolled the first patient at OU...

    Median Technologies announces results of REALITY study of eyonis LCS lung cancer diagnostic

    Median Technologies has announced that eyonis LCS, its proprietary AI/machine learning powered Software as a Medical Device (SaMD) for lung cancer screening (LCS), met...

    New report supports SciBase’s melanoma detection AI device

    Swedish medical detection company SciBase Holding has seen its artificial intelligence (AI) powered device for detecting melanomas, dubbed Nevisense, validated as part of a...

    RenovoRx continues drug-device combo Phase III trial in pancreatic cancer

    Another site has enrolled its first patient in RenovoRx’s Phase III trial evaluating a drug-device combination therapy to treat locally advanced pancreatic cancer. The latest...

    Invenio completes enrolment in AI-based lung cancer imaging trial

    California-based diagnostic imaging firm, Invenio Imaging, has announced that it has completed enrolment for a pivotal trial of its artificial intelligence (AI) driven software...

    PhotoPharmics reaches a third of enrolment goal for PD light therapy trial

    PhotoPharmics has enrolled the first 100 subjects in its clinical trial investigating a light therapy device designed for the treatment of Parkinson’s disease (PD). The...

    Fractyl Health touts positive year-long weight loss results for Revita device

    Fractyl Health has reported positive results for its hydrothermal ablation device Revita, as the company looks to battle the booming pharmaceutical weight loss therapy...

    Galvanize concludes enrolment in study of Aliya PEF system for NSCLC

    Galvanize Therapeutics has announced the completion of patient enrolment in the AFFINITY study assessing the Aliya pulsed electric field (PEF) system in treating late-stage...
    1...678...49Page 7 of 49

    Latest articles

    Popular articles

    Featured

    Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    © Copyright - Guided Solutions - Global Executive Search in Medical Devices